IDENTIC PHARMACEUTICAL
Live / Applied — Fourth extension granted (statement of use) (as of 30 Jun 2025)
What this means for you
Not registered yet, but its 27 Apr 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97384190
- Mark type
- Stylized text
- Filed
- 27 Apr 2022
- Published for opposition
- 16 May 2023
- Attorney of record
- B. Brett Heavner
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of central nervous system diseases and disorders; pharmaceutical preparations for the treatment of polycystic kidney diseases and disorders
- Class 035 — Advertising and business services: Distributorship services in the field of pharmaceutical drugs
- Class 044 — Medical, beauty and agricultural services: Providing health and medical information via a website; providing pharmaceutical advice via a website; providing treatment and disease management via a website being the provision of health and medical information via a website
Owner
- Otsuka America Pharmaceutical, Inc., Rockville, MD, US
- Otsuka America Pharmaceutical, Inc., Rockville, MD, US
Prosecution history
- 12 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 01 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Jun 2025 — SOU EXTENSION 4 GRANTED
- 30 Jun 2025 — SOU EXTENSION 4 FILED
- 30 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Jan 2025 — SOU EXTENSION 3 GRANTED
- 13 Jan 2025 — SOU EXTENSION 3 FILED
- 13 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 21 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Jun 2024 — SOU EXTENSION 2 GRANTED
- 21 Jun 2024 — SOU EXTENSION 2 FILED
- 21 Jun 2024 — SOU TEAS EXTENSION RECEIVED
- 10 Jan 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Jan 2024 — SOU EXTENSION 1 GRANTED